Related Experiment Video
Updated: Sep 30, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Traditional clinical risk factors predict clopidogrel hypo-responsiveness in unselected patients undergoing
Hanna Ratcovich1, Lene Holmvang1, Pär Inge Johansson2
1a Department of Cardiology , Copenhagen University Hospital, Rigshospitalet , Copenhagen , Denmark and.
Insights
The PREDICT score effectively identifies patients at high risk for high platelet reactivity to clopidogrel after PCI. However, it shows a weaker correlation with aspirin response, suggesting targeted platelet function testing for high-risk individuals.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- High and low platelet reactivity (HPR/LPR) to clopidogrel and aspirin are linked to adverse events post-percutaneous coronary intervention (PCI).
- Predictive clinical risk scores aim to stratify patient risk for tailored antiplatelet therapy.
Purpose of the Study:
- To evaluate the PREDICT score's ability to identify patients with HPR and LPR following PCI.
- To assess the correlation between the PREDICT score and platelet reactivity to clopidogrel and aspirin.
Main Methods:
- 923 patients undergoing non-emergent PCI were enrolled.
- Platelet reactivity was measured using Multiplate assays, defining HPR and LPR by upper and lower quintiles.
- Patients were assigned PREDICT score points based on clinical factors: age, left ventricular function, kidney function, ACS, and diabetes.
Main Results:
- A significant association was found between higher PREDICT scores and increased risk of HPR to clopidogrel (ADP).
- The PREDICT score demonstrated an inverse relationship with LPR to clopidogrel (ADP).
- No clear association was observed between the PREDICT score and HPR to aspirin (AA).
Conclusions:
- The PREDICT score is valuable for identifying patients at high risk of HPR to clopidogrel, potentially guiding antiplatelet therapy selection.
- The PREDICT score's utility in predicting aspirin response is limited.
- Platelet function testing may be reserved for patients with a high clinical likelihood of HPR, as indicated by the PREDICT score.
Abstract:
High and low platelet reactivity, HPR and LPR respectively, to clopidogrel and aspirin have previously been associated with adverse events following percutaneous coronary intervention (PCI). The aim is to test the ability of a previously developed clinical risk-score, the PREDICT score, to identify patients with HPR and LPR. Nine hundred and twenty-three consecutive patients undergoing non-emergent PCI were enrolled. Platelet reactivity (PR) was determined using Multiplate assays. Patients were grouped into quintiles based on their PR values. Upper and lower quintiles defined HPR and LPR, respectively, whereas quintiles 2-4 defined normal responders. All patients were assigned PREDICT score points in clinical categories (age > 65, reduced left ventricular function, reduced kidney function, acute coronary syndrome (ACS) and diabetes). We found an association between the cumulative number of PREDICT score variables and the incidence of HPR for clopidogrel (HPR (ADP)) (p < 0.001) and aspirin (HPR (AA)) (p = 0.007). In addition, the higher the PREDICT score, the higher the risk of HPR (ADP) (1-3 points, odds ratio (OR) 3.82 (95% CI 1.5-9.73, p = 0.005); 4-6 points OR 4.11 (95% CI 1.61-10.52, p = 0.003); 7-9 points OR 9.84 (95% CI 3.49-27.7, p < 0.001); patients with 0 PREDICT points defined the reference population). The relation was reversed with regards to clopidogrel LPR (LPR (ADP)). On the other hand, there was no clear association between PREDICT score and AA response. The PREDICT score was able to identify patients with a high risk of HPR (ADP) but did not correlate well with PR to AA. In order to assure an optimal tailoring of antiplatelet therapy, costly platelet function tests (PFTs) could be reserved for patients with high clinical likelihood for HPR.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drug Toxicity: Risk factors
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care